Keywords: taigen, enter, development, deal, taiwan-based, privately-held, drugmaker
TaiGen and P&G enter development deal
Article | 17 January 2005
Taiwan-based privately-held drugmaker TaiGen Biotechnology says it has entered into an agreement with Procter & Gamble Pharmaceuticals of the USA for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- SciClone gains China rights to Zensun's Neucardin
